Wednesday, September 16, 2026Latest filing Sep 14, 2026

Eleanor Holmes Norton Periodic Transaction Report

Filed Oct 21, 2025 · House Clerk · 1 transaction

U.S. Representative · D · DC-00 · All trades by Eleanor Holmes Norton

On October 21, 2025, Rep. Eleanor Holmes Norton (D-DC-00) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 sale) dated Oct 14, 2025.

The filing covers 1 ticker, including $BRK.B.

Reported amount ranges sum to $15K–$50K. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 7 days.

Source document: House Clerk filing 20033318

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Eleanor Holmes Norton · Sold $BRK.B · Oct 14 · $15K–$50K

0.50LOW
Disclosure speedx 0.250.60
Trade sizex 0.250.50
Cluster activityx 0.150.00
Track recordx 0.350.63

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Eleanor Holmes Norton

Get an email the moment Eleanor Holmes Norton files the next one. Free, no card, no spam.

Follow free →
1
Transactions
0 / 1
Buys / sells
1
Tickers
7d
Longest lag

Tickers in this filing

Transactions disclosed

Trade dateTickerAssetTypeOwnerAmountLag
Oct 14, 2025BRK.BBerkshire Hathaway Inc. New Common Stock (BRK.B)sell$15K–$50K7d

Other recent filings by Eleanor Holmes Norton

← All congressional filings, newest first

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →